Article tools
Author information
Published in Volume 100, Issue 5 (September 1,1997)
J. Clin. Invest. 100(5): 1193-1198 (1997). doi:10.1172/JCI119631.
Copyright © 1997, The American Society for Clinical Investigation.

Research Article

Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.

C A Head, C Brugnara, R Martinez-Ruiz, R M Kacmarek, K R Bridges, D Kuter, K D Bloch and W M Zapol

Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, Massachusetts 02115, USA. head@etherdome.mgh.harvard.edu

Published September 1, 1997

The hallmark of sickle cell disease (SCD) is the polymerization of deoxygenated sickle hemoglobin (HbS). In SCD patients, one strategy to reduce red blood cell (RBC) sickling is to increase HbS oxygen affinity. Our objective was to determine if low concentrations of nitric oxide (NO) gas would augment the oxygen affinity of RBCs containing homozygous HbS (SS). Blood containing normal adult hemoglobin (AA) or SS RBCs was incubated in vitro in the presence of varying concentrations of NO up to 80 ppm, and oxygen dissociation curves (ODCs) were measured. In addition, blood was obtained from three AA and nine SS volunteers, before and after breathing 80 ppm NO in air for 45 min, and the ODCs were measured. Exposure of SS RBCs to 80 ppm NO in vitro for 5 min or longer decreased the partial pressure of oxygen at which hemoglobin is 50% saturated with oxygen (P50), an average of 15% (4.8+/-1.7 mmHg mean+/-SE; P < 0.001). The increase in SS RBC oxygen affinity correlated with the NO concentration. The P50 of AA RBCs was unchanged (P > 0.1) by 80 ppm NO. In SS volunteers breathing 80 ppm NO for 45 min, the P50 decreased (P < 0.001) by 4.6+/-2.0 mmHg. 60 min after NO breathing was discontinued, the RBC P50 remained decreased in five of seven volunteers in whom the ODC was measured. There was no RBC P50 change (P > 0.1) in AA volunteers breathing NO. Methemoglobin (Mhb) remained low in all subjects breathing NO (SS Mhb 1.4+/-0.5%), and there was no correlation (r = 0.02) between the reduction in P50 and the change in Mhb. Thus, low concentrations of NO augment the oxygen affinity of sickle erythrocytes in vitro and in vivo without significant Mhb production. These results suggest that low concentrations of NO gas may offer an attractive new therapeutic model for the treatment of SCD.

This article Copyright © 1997, The American Society for Clinical Investigation.

Articles that cite
this article:

Bench to Bedside Nitric Oxide in Emergency Medicine
Bernard L. Lopez, Theodore A. Christopher, Sharon K. Griswold, Ma Xin-liang
Acad Emerg Med 7(3):285. [CrossRef]

Can we just say NO to sickle cell anemia?
Ronald L. Nagel
J Clin Invest 104(7):847. [CrossRef]

Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity
Borys W. Hrinczenko, James S. Nichols, Margaret E. Pease-fye, Constance T. Noguchi, Griffin P. Rodgers, Mark T. Gladwin, Alan N. Schechter, James H. Shelhamer, Lewis K. Pannell, Deirdre A. Conway
J Clin Invest 104(7):937. [CrossRef]

Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium
Sharon L. Space, Peter A. Lane, Cheryl K. Pickett, John V. Weil
Am J Hematol 63(4):200. [CrossRef]

Novel approaches to treatment of sickle cell anaemia
Timothy E Mitchell, Martin H Steinberg
Expert Opin Invest Drugs 8(11):1823. [CrossRef]

Developing treatment for sickle cell disease
Carlo Brugnara, Martin H Steinberg
Expert Opin Invest Drugs 11(5):645. [CrossRef]

Sickle cell disease: current therapeutic approaches
Osheiza Abdulmalik, Daniel Obeng, Toshio Asakura
eotp 15(11):1497. [CrossRef]

Nitric oxide metabolism and the acute chest syndrome of sickle cell anemia
Kevin J. Sullivan, Niranjan Kissoon, Cynthia Gauger
Pediatr Crit Care Med 9(2):159. [CrossRef]

Sickle cell disease: The neurological complications
Mara Prengler, Steven G. Pavlakis, Isak Prohovnik, Robert J. Adams
Ann Neurol 51(5):543. [CrossRef]

Therapeutic challenges in childhood sickle cell disease Part 1: current and future treatment options
Persis J. Amrolia, Antonio Almeida, Christina Halsey, Irene A. G. Roberts, Sally C. Davies
Br J Haematol 120(5):725. [CrossRef]

Asthma Therapy with Agents Preventing Leukotriene Synthesis or Action
Jeffrey M. Drazen
Proc Assoc Am Phys 111(6):547. [CrossRef]

Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients
Nicola Conran, Camila Oresco-santos, Heloisa C. Acosta, Andre Fattori, Sara T. O. Saad, Fernando F. Costa
Br J Haematol 124(4):547. [CrossRef]

Effect of nitric oxide and nitric oxide donors on red blood cell oxygen transport
Borys W. Hrinczenko, Abdu I. Alayash, David A. Wink, Mark T. Gladwin, Griffin P. Rodgers, Alan N. Schechter
Br J Haematol 110(2):412. [CrossRef]

Biological action of nitric oxide donor compounds on platelets from patients with sickle cell disease
Traci Heath Mondoro, Beth Brockner Ryan, Borys W. Hrinczenko, Alan N. Schechter, Jaroslav G. Vostal, Abdu I. Alayash
Br J Haematol 112(4):1048. [CrossRef]


Christopher Reiter, Mark Gladwin
Curr Opin Hematol 10(2):99. [CrossRef]

NO-body??s Perfect
William E. Hurford, Luca M. Bigatello
Anaesthesiology 96(6):1285. [CrossRef]


MARTIN Steinberg, GRIFFIN Rodgers
Medicine (Balt) 80(5):328. [CrossRef]

Acute chest syndrome of sickle cell disease: new light on an old problem
Marie J. Stuart, B.N. Yamaja Setty
Curr Opin Hematol 8(2):111. [CrossRef]

Inhaled Nitric Oxide for Treatment of Sickle Cell Stroke
Pedro Montero-huerta, Dean R. Hess, C Alvin Head
Anaesthesiology 105(3):619. [CrossRef]

Inhaled Nitric Oxide: Current Concepts
William E. Hurford
31(1):81. [CrossRef]

SICKLE CELL DISEASE: ROLE OF REACTIVE OXYGEN AND NITROGEN METABOLITES
Katherine C Wood, D Neil Granger
Clin Exp Pharmacol Physiol 34(9):926. [CrossRef]